1. The effect of dopaminergic neuron transplantation and melatonin co-administration on oxidative stress-induced cell death in Parkinson's disease.
- Author
-
Asemi-Rad, Azam, Moafi, Maral, Aliaghaei, Abbas, Abbaszadeh, Hojjat-Allah, Abdollahifar, Mohammad-Amin, Ebrahimi, Mohammad-Javad, Heidari, Mohammad Hasan, and Sadeghi, Yousef
- Subjects
PARKINSON'S disease ,CELL death ,DOPAMINERGIC neurons ,CELL size ,WESTERN immunoblotting ,SUBSTANTIA nigra ,NEUROGLIA - Abstract
A gradual degeneration of the striatum and loss of nigral dopamine cells are characteristic of Parkinson's disease. Nowadays, combination therapy for neurodegenerative disease is considered. This study aimed to investigate the effects of melatonin and dopaminergic neurons derived from adipose tissue stem cells (ADSCs) in a rat model of Parkinson's disease. Parkinson's disease was induced in rats using neurotoxin 6-Hydroxydopamine. The treatment was performed using melatonin and dopaminergic neurons transplantation. Subsequently, behavioral tests, western blot analysis for Caspase-3 expression, GSH (Glutathione) content and stereology analysis for the volume and cell number of substantia nigra and striatum were performed. Treatment with melatonin and dopaminergic neuron transplantation increased the number of neurons in substantia nigra and striatum while the number of glial cell and the volume of substantia nigra and striatum did not show significant change between groups. Western blot analysis for caspase 3 indicated the significant differences between groups. The results also indicated the increased level of glutathione (GSH) content in treatment groups. this study showed that combination therapy with melatonin and dopaminergic neurons could greatly protect the neurons, reduce oxidative stress and improve the symptoms of PD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF